Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial
Authors
Illerhaus, GCwynarski, K
Pulczynski, E
Ponzoni, M
Deckert, M
Politi, L
Fox, C
La Rose, P
Ambrosetti, A
Roth, A
Hemmaway, A
Ilariucci, F
Linton, Kim M
Soffietti, R
Pukrop, T
Binder, M
Balzarotti, M
Fabbri, A
Johnson, P
Gorlov, J
Cavalli, F
Finke, J
Schorb, E
Reni, M
Zucca, E
Ferrer, A
Issue Date
2015